In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Aquestive Therapeutics Inc (AQST – Research
Category: Healthcare
Cantor Fitzgerald Believes BioDelivery (NASDAQ: BDSI) Won’t Stop Here
Cantor Fitzgerald analyst Brandon Folkes maintained a Buy rating on BioDelivery (BDSI – Research Report) today and set a price
Cantor Fitzgerald Keeps Their Buy Rating on Collegium Pharmaceutical (COLL)
In a report released today, Brandon Folkes from Cantor Fitzgerald maintained a Buy rating on Collegium Pharmaceutical (COLL – Research
Eli Lilly & Co (LLY) Receives a Hold from Merrill Lynch
Merrill Lynch analyst Jason Gerberry reiterated a Hold rating on Eli Lilly & Co (LLY – Research Report) yesterday and
Bluebird Bio (BLUE) Gets a Hold Rating from Cantor Fitzgerald
In a report released today, Elemer Piros from Cantor Fitzgerald maintained a Hold rating on Bluebird Bio (BLUE – Research
Gilead Sciences (GILD) Receives a Buy from Mizuho Securities
In a report released today, Salim Syed from Mizuho Securities assigned a Buy rating to Gilead Sciences (GILD – Research
Amgen Inc (AMGN) Receives a Buy from Mizuho Securities
In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Amgen Inc (AMGN – Research